Showing results (2011-2020 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|November 1, 1991
Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatinH Kobayashi, Y Takemura, H Miyachi, et al.Investigational New Drugs|November 1, 1991
Phase II trial of indicine N-oxide in relapsed pediatric solid tumors. A report from the Childrens Cancer Study GroupJ S Miser, W A Smithson, W Krivit, et al.Investigational New Drugs|November 1, 1991
Phase II study of amonafide in advanced pancreatic adenocarcinomaK Linke, R Pazdur, J L Abbruzzese, et al.Investigational New Drugs|December 12, 2007
Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunineAshish Aggarwal, Anna Kruczynski, Anthony Frankfurter, et al.Investigational New Drugs|December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming unitsL L Siu, D D Von Hoff, A Rephaeli, et al.Investigational New Drugs|December 16, 1998
Preclinical antitumor efficacy of analogs of XK469: sodium-(2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]propionateT H Corbett, P LoRusso, L Demchick, et al.Investigational New Drugs|December 16, 1998
Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I studyD Lüftner, B Flath, C Akrivakis, et al.Investigational New Drugs|December 16, 1998
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancerM J Edelman, F J Meyers, T Grennan, et al.Investigational New Drugs|January 1, 1996
Cellular transport of CI-980K E Hook, S A Przybranowski, W R LeopoldInvestigational New Drugs|January 1, 1996
Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell linesT Takagi, Y Yazawa, K Suzuki, et al.Pageof 372